Effects of combined use of ribociclib with PARP1 inhibitor on cell kinetics in breast cancer
In conclusion, the results obtained from cell kinetics parameters demonstrated the anticancer and antiproliferative effects of the combination of VLM and DPQ on breast cancer cells.PMID:38638847 | PMC:PMC11024784 | DOI:10.3892/ol.2024.14376
Source: Oncology Letters - Category: Cancer & Oncology Authors: Ercan Pulat Mehmet R Top çul Source Type: research